Clinical Trial Update: Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease [Phase 2]

View source ↗

Summary

Phase II study evaluating filgrastim (G-CSF) plus ABVD chemotherapy in HIV-associated Hodgkin's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Hodgkin Disease

Drugs mentioned

• ABVD
• Filgrastim (filgrastim)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Hodgkin's Disease | Phase 2 | Status: COMPLETED